Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
SAN ANTONIO, Texas, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Wytec (OTCQB:WYTC) has announced today, plans to uplist to the Nasdaq Capital Markets to accelerate their Pilot Smart Sensor Project to be demonst
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 18'th Oct 2024
NOVATO, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rar
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 18'th Oct 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardio
Flux Power Receives Non-Compliance Letter from Nasdaq
04:05pm, Friday, 18'th Oct 2024
VISTA, Calif.--(BUSINESS WIRE)--Flux Power Receives Non-Compliance Letter from Nasdaq.
Nasdaq Resumes Trading in Nebius Group N.V.
04:05pm, Friday, 18'th Oct 2024
NEW YORK, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Nebius Group N.V. (Nasdaq: NBIS) at 9:00 a.m. Eastern Time on October 21, 202
Nasdaq Index Today: Netflix Rally Leads Gains as Dow Falters on AmEx Slump
11:54am, Friday, 18'th Oct 2024
Nasdaq rallies as Netflix jumps 11% on strong earnings, while AmEx drags down Dow. Will tech stocks keep leading the market's bullish momentum?
Live Market Updates: Nasdaq Composite Up | NFLX & ISRG Crush Earnings
07:48am, Friday, 18'th Oct 2024
Major indexes faded late in Thursday's trading, with the Nasdaq Composite finishing up just .036%.
Nasdaq Futures Rise as Netflix Soars 4% on Earnings, Dow and S&P 500 Eye 6-Week Streak
06:12am, Friday, 18'th Oct 2024
U.S. stocks on track for weekly gains, with the Dow and S&P 500 set to hit their longest 2024 streak. Netflix jumps 4% on strong Q3 earnings.
Nebius to resume Nasdaq trading after severing ties with Russia and Yandex
05:48am, Friday, 18'th Oct 2024
Nebius, the company formerly known as Yandex that's now focused on cloud infrastructure for AI uses (aka “AI compute”), is to begin trading on the public markets once again — more than two years
Telix Files Form 20-F Registration Statement for Nasdaq ADS
05:28pm, Thursday, 17'th Oct 2024
MELBOURNE, Australia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registrati
Nasdaq Turns to AI to Improve Bank and Insurance Risk Assessment
05:07pm, Thursday, 17'th Oct 2024
Nasdaq has introduced technology to calculate investment portfolio risk using machine learning. The new functionality, announced Thursday (Oct. 17), will be woven into Nasdaq's Calypso platform, us
Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
04:05pm, Thursday, 17'th Oct 2024
New York, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) (“Fresh2” or the “Company”), a B2B e-commerce and supply chain management company within the restaurant and
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Should You Buy?
11:05am, Thursday, 17'th Oct 2024
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sky Quarry to Ring the Nasdaq Closing Bell on Friday, October 25, 2024
10:55am, Thursday, 17'th Oct 2024
WOODS CROSS, Utah, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sky Quarry Inc. (NASDAQ: SKYQ) ("Sky Quarry" or the "Company"), an integrated energy solutions company committed to revolutionizing the waste aspha
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
08:45am, Thursday, 17'th Oct 2024
PRINCETON, NJ, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeuti
